$0.350000
00.00%
After Hours: 9:29 AM EDT
15 minutes delayed
Comments
Loading...
TransCode Therapeutics (NASDAQ:RNAZ) Stock, Earnings Estimates, EPS, And Revenue
TransCode Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 12
EPS Estimate
$-0.510
Quarterly Revenue Estimate
–
Annual Revenue
(as of Jun 30)
(as of Jun 30)
–
Analyze the earnings history of TransCode Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
TransCode Therapeutics (RNAZ) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Jun 2024 | 2024-08-14 | $-0.74 | $-0.58 | -27.6 % |
| Mar 2024 | 2024-05-15 | $-0.65 | $-0.50 | -30.0 % |
| Mar 2024 | 2024-04-01 | $-0.93 | $-10.80 | 91.4 % |
| Sep 2023 | 2023-11-14 | $-67.20 | $-43.60 | -54.1 % |
TransCode Therapeutics (RNAZ) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is TransCode Therapeutics (NASDAQ:RNAZ) reporting earnings?
TransCode Therapeutics (RNAZ) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
What were the latest earnings per share (EPS) for TransCode Therapeutics (NASDAQ:RNAZ)?
The Actual EPS was $-0.74, which missed the estimate of $-0.58.
What were TransCode Therapeutics’s (NASDAQ:RNAZ) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.